XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offerings [Member]
Common Stock
Common Stock
At The Market Offerings [Member]
Additional Paid-In Capital
Additional Paid-In Capital
At The Market Offerings [Member]
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance at Dec. 31, 2023 $ 1,050,169   $ 9   $ 2,710,797   $ (2,258) $ (1,658,379)
Beginning balance, shares at Dec. 31, 2023     92,997,158          
Issuance of common stock   $ 55,959   $ 1   $ 55,958    
Issuance of common stock, shares       2,209,938        
Exercise of stock options 1,958       1,958      
Exercise of stock options, shares     110,734          
Vesting of restricted stock units, shares     1,015,543          
Stock-based compensation 34,176       34,176      
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities (821)           (821)  
Other comprehensive income (loss) - unrealized gain on equity method investment 2,132           2,132  
Reclassification of other comprehensive income (loss) - equity method investment 2,132           2,132  
Net Income (Loss) (107,436)             (107,436)
Ending balance at Mar. 31, 2024 1,036,137   $ 10   2,802,889   (947) (1,765,815)
Ending balance, shares at Mar. 31, 2024     96,333,373          
Beginning balance at Dec. 31, 2024 $ 871,956   $ 10   3,048,741   605 (2,177,400)
Beginning balance, shares at Dec. 31, 2024 102,029,594   102,029,594          
Vesting of restricted stock units, shares     1,510,091          
Stock-based compensation $ 21,840       21,840      
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities 452           452  
Net Income (Loss) (114,329)             (114,329)
Ending balance at Mar. 31, 2025 $ 779,919   $ 10   $ 3,070,581   $ 1,057 $ (2,291,729)
Ending balance, shares at Mar. 31, 2025 103,539,685   103,539,685